Working… Menu

Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00388427
Recruitment Status : Completed
First Posted : October 16, 2006
Last Update Posted : May 28, 2015
Bristol-Myers Squibb
Information provided by (Responsible Party):
Edward Chu, MD, University of Pittsburgh

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2009
Actual Study Completion Date : February 2013